分裂设计方法增强了基于连接体的CAR-T细胞对多种B细胞恶性瘤的治疗疗效
Shuhong Li1, Licai Shi1, Lijun Zhao1
1State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, China.
Nature communications
|November 11, 2024
概括
这项研究引入了一种新型的分裂嵌合抗原受体 (CAR) -T细胞策略,使用天然配体来防止癌症治疗中的免疫逃逸. 这种方法提高了B细胞恶性瘤的CAR-T细胞疗效和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 癌症免疫逃脱是CAR-T细胞疗法的一个重大挑战.
- 多特异性CAR-T细胞策略旨在通过向癌细胞上的多个受体来克服这一问题.
- 像APRIL和BAFF这样的天然配体提供了针对特定向的潜力.
研究的目的:
- 开发一个分裂的CAR设计,以保持连接体的自然形状.
- 为了提高CAR-T细胞的识别,有效性和安全性.
- 为了研究抗瘤活性对抗B细胞恶性瘤.
主要方法:
- 提出了一个分割的CAR设计,具有通用受体和基于连接体的开关分子.
- 优化了链区域和切换标签站点.
- 在雌性小鼠B细胞恶性瘤模型中评估了CAR-T细胞战略.
主要成果:
- 分裂的CAR设计保留了连接体的原生三元体结构 (APRIL,BAFF).
- 促进了CAR-T细胞和癌细胞之间的最佳免疫突触形成.
- 对各种B细胞恶性瘤模型表现出显著的抗瘤活性.
结论:
- 基于连接体的分裂CAR设计提供了一种新的方法来优化CAR识别并提高治疗疗效.
- 这种策略显示出防止因抗原丢失或切换而导致免疫逃逸的潜力.
- 该设计可以广泛应用于利用自然受体或连接体的细胞疗法,改善临床翻译和安全性.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480


